[go: up one dir, main page]

PE20150620A1 - SIRNA MOLECULES THAT INTERFERE WITH THE EXPRESSION OF THE ADRENERGIC RECEPTOR BETA 2 (ADRB2) - Google Patents

SIRNA MOLECULES THAT INTERFERE WITH THE EXPRESSION OF THE ADRENERGIC RECEPTOR BETA 2 (ADRB2)

Info

Publication number
PE20150620A1
PE20150620A1 PE2015000283A PE2015000283A PE20150620A1 PE 20150620 A1 PE20150620 A1 PE 20150620A1 PE 2015000283 A PE2015000283 A PE 2015000283A PE 2015000283 A PE2015000283 A PE 2015000283A PE 20150620 A1 PE20150620 A1 PE 20150620A1
Authority
PE
Peru
Prior art keywords
adrb2
expression
adrenergic receptor
receptor beta
interfere
Prior art date
Application number
PE2015000283A
Other languages
Spanish (es)
Inventor
Anton Ana Isabel Jimenez
Fajardo Victoria Gonzalez
Palomar Veronica Ruz
Original Assignee
Sylentis Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sylentis Sau filed Critical Sylentis Sau
Priority to PE2015000283A priority Critical patent/PE20150620A1/en
Publication of PE20150620A1 publication Critical patent/PE20150620A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A MOLECULAS DE ARN DE INTERFERENCIA DE CADENA CORTA (siARN) QUE DISMINUYEN O INHIBEN LA EXPRESION DEL RECEPTOR ADRENERGICO BETA 2 (ADRB2), POR LO CUAL SON UTILES EN EL TRATAMIENTO Y/O PREVENCION DE LA PRESION INTRAOCULAR. TAMBIEN SE REFIERE A COMPOSICIONES QUE COMPRENDEN DICHAS MOLECULAS.THE INVENTION REFERS TO SHORT-CHAIN INTERFERENCE RNA MOLECULES (siARN) WHICH DECREASE OR INHIBIT THE EXPRESSION OF THE ADRENERGIC RECEPTOR BETA 2 (ADRB2), THEREFORE THEY ARE USEFUL IN THE TREATMENT AND / OR PREVENTION OF INTRAOCULAR PRESSURE. IT ALSO REFERS TO COMPOSITIONS THAT INCLUDE SUCH MOLECULES.

PE2015000283A 2012-09-05 2012-09-05 SIRNA MOLECULES THAT INTERFERE WITH THE EXPRESSION OF THE ADRENERGIC RECEPTOR BETA 2 (ADRB2) PE20150620A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PE2015000283A PE20150620A1 (en) 2012-09-05 2012-09-05 SIRNA MOLECULES THAT INTERFERE WITH THE EXPRESSION OF THE ADRENERGIC RECEPTOR BETA 2 (ADRB2)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PE2015000283A PE20150620A1 (en) 2012-09-05 2012-09-05 SIRNA MOLECULES THAT INTERFERE WITH THE EXPRESSION OF THE ADRENERGIC RECEPTOR BETA 2 (ADRB2)

Publications (1)

Publication Number Publication Date
PE20150620A1 true PE20150620A1 (en) 2015-05-11

Family

ID=53487480

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015000283A PE20150620A1 (en) 2012-09-05 2012-09-05 SIRNA MOLECULES THAT INTERFERE WITH THE EXPRESSION OF THE ADRENERGIC RECEPTOR BETA 2 (ADRB2)

Country Status (1)

Country Link
PE (1) PE20150620A1 (en)

Similar Documents

Publication Publication Date Title
MX2014001717A (en) IMMUNOTHERAPEUTIC COMPOSITIONS OF LEVADURA-MUCINA 1 (MUC1) AND USES OF THE SAME.
MX385048B (en) COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF THE ALAS1 GENE.
PH12019550076A1 (en) SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
UY36075A (en) TUBULISINE DERIVATIVES
MY201504A (en) Complement component c5 irna compositions and methods of use thereof
MX2018006217A (en) APELINE RECEIVER AGONISTS AND METHODS OF USE.
MX382225B (en) COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF THE HYDROXY ACID OXIDASE 1 (GLYCOLATE OXIDASE) GENE (HAO1).
PH12017502255B1 (en) Nrf2 regulators
CO2018007221A2 (en) Heteroarylhydroxypyrimidinones as apeline receptor agonists (apj)
SG10201804472YA (en) SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
MX2018004344A (en) 2,4-DIHIDROXI-NICOTINAMIDS AS AGELISTS OF THE APELINE RECEIVER (APJ).
MX2017001290A (en) Fabric treatment composition comprising an aminosiloxane polymer nanoemulsion.
MX372754B (en) METHODS AND COMPOSITIONS RELATED TO P62 FOR THE TREATMENT AND PROPHYLAXIS OF CANCER.
MX385871B (en) COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF THE LECT2 GENE.
PH12016500574A1 (en) Compositions and methods for inhibiting expression of the alas1 gene
BR112018000217A2 (en) improved nanoparticle distribution systems
TN2018000351A1 (en) Oxaborole esters and uses thereof
CO6321288A2 (en) SALES OF HIV INHIBITING COMPOUNDS
PE20150619A1 (en) SIARN MOLECULES INTERFERING WITH THE EXPRESSION OF THE VANILOID-1 RECEPTOR (TRPV1)
IN2014CH00151A (en)
PH12017501601A1 (en) Use of isolated fractions of mastic gum for treating optic neuropathy
BR112016028948A2 (en) ? biphasic composition?
MX2019008375A (en) Thiobenzoimidazole as fungicides.
ECSP15011105A (en) siRNA AND ITS USE IN THE METHODS AND COMPOSITIONS FOR THE TREATMENT AND / OR PREVENTION OF EYE DISORDERS
CY1121216T1 (en) METHODS FOR RELIEF OF SYMPTOMS OF MULTIPLE SCRIENING BASED ON COMPOSITIONS CONTAINING AQUACORINE

Legal Events

Date Code Title Description
FC Refusal